AVNS - CIK 0001606498
AVANOS MEDICAL, INC. (AVNS) reported net income of -$72.90M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$72.90M | +81.4% |
| FY 2024 | -$392.10M | -534.5% |
| FY 2023 | -$61.80M | -222.4% |
| FY 2022 | $50.50M | +701.6% |
| FY 2021 | $6.30M | +121.7% |
| FY 2020 | -$29.00M | +36.8% |
| FY 2019 | -$45.90M | -179.8% |
| FY 2018 | $57.50M | -27.5% |
| FY 2017 |
AVANOS MEDICAL, INC. (AVNS) reported net income of -$72.90M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2012 and fiscal 2025, AVANOS MEDICAL, INC.'s net income declined from $152.60M to -$72.90M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $79.30M |
| +99.2% |
| FY 2016 | $39.80M | +109.3% |
| FY 2015 | -$426.30M | -1673.1% |
| FY 2014 | $27.10M | -82.5% |
| FY 2013 | $154.60M | +1.3% |
| FY 2012 | $152.60M | - |